Price Action and Market Performance
Trading below all key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day averages — Nirman Agri Genetics Ltd has underperformed not only its sector but also the broader market indices. The stock declined by 2.00% on the latest session, contrasting with a 0.51% gain in the Sensex. Over the last three months, the stock has plunged 42.04%, while the Sensex has fallen a modest 3.16%. The year-to-date loss stands at 56.50%, far exceeding the Sensex’s 12.72% decline. This steep sell-off has been largely indiscriminate, reflecting a lack of confidence among market participants despite some pockets of financial improvement. what is driving such persistent weakness in Nirman Agri Genetics Ltd when the broader market is in rally mode?
Financial Performance: A Tale of Contrasts
Interestingly, the recent quarterly and half-yearly financials present a different story from the stock’s price action. The company reported net sales of ₹124.07 crores in the latest six months, marking a robust growth of 215.30% compared to the previous period. Profit after tax (PAT) also surged by 110.65% to ₹13.65 crores, while the highest quarterly PBDIT reached ₹7.31 crores. These figures indicate operational improvements and a positive earnings trajectory over the recent quarters. could these financial gains signal a potential stabilisation despite the ongoing price slump?
However, the longer-term picture remains challenging. Over the past year, profits have declined by 30%, and the stock has generated a negative return of 85.11%. The company has also failed to declare results in the last six months, which adds to the uncertainty surrounding its financial transparency and investor confidence. This disconnect between improving short-term earnings and a collapsing share price highlights the complexity of the situation facing Nirman Agri Genetics Ltd.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Valuation Metrics and Market Perception
Valuation data for Nirman Agri Genetics Ltd is notably sparse, with key multiples such as P/E, Price to Book Value, EV/EBITDA, and EV/Sales not available. The absence of these metrics complicates a straightforward assessment of the stock’s relative value. The company’s Price to Book Value is reported as 0.2, which typically suggests an attractive valuation, but this figure must be interpreted cautiously given the lack of comprehensive data and the company’s micro-cap status. The dividend yield is also not available, though a dividend of ₹2 per share was declared with an ex-dividend date of 25 Sep 2024.
Given the stock’s dramatic price decline and limited valuation transparency, should you be looking at Nirman Agri Genetics Ltd as a potential entry point or is there more downside ahead?
Technical Indicators and Trading Patterns
Technical data for Nirman Agri Genetics Ltd is limited, with no clear overall trend or historical trend data available. The stock is trading below all major moving averages, which generally signals bearish momentum. Immediate resistance is noted around ₹29.05 (20-day moving average), with stronger resistance levels at ₹41.26 (100-day) and ₹48.67 (200-day). Delivery volumes have shown some recent increase, with a 53.45% rise over the past month and a 6.18% increase on the latest trading day compared to the 5-day average, indicating some trading interest despite the downtrend. However, the lack of a clear technical trend and the absence of detailed momentum indicators limit the scope for technical analysis.
Quality and Institutional Holding
Quality assessment data is not available for Nirman Agri Genetics Ltd, and the company has not disclosed recent results for over six months, which raises questions about financial reporting consistency. Institutional holding data is also not provided, which could have offered insights into the confidence levels of large investors at these depressed price levels. The absence of this information adds to the opacity surrounding the company’s current standing and future prospects. how does the lack of transparency affect the stock’s risk profile for investors?
Nirman Agri Genetics Ltd or something better? Our SwitchER feature analyzes this micro-cap Other Agricultural Products stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Key Data at a Glance
₹124.07 crores (↑ 215.30%)
₹13.65 crores (↑ 110.65%)
-85.11%
-56.50%
0.2
₹2 per share (Ex-Date: 25 Sep 2024)
5, 20, 50, 100, 200-day
Other Agricultural Products
Conclusion: Bear Case and Silver Linings
The trajectory of Nirman Agri Genetics Ltd is marked by a stark contrast between its collapsing share price and recent improvements in sales and profitability. While the company’s latest financials show encouraging growth in net sales and PAT, the stock’s persistent underperformance and lack of comprehensive valuation and quality data suggest caution may be warranted. The absence of recent results and limited technical clarity further complicate the picture. Should you buy, sell, or hold at these levels? Explore the complete multi-factor analysis of Nirman Agri Genetics Ltd to find out what the data signals at this all-time low.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
